These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25728703)

  • 1. The relevance of intestinal dysbiosis in liver transplant candidates.
    Grąt M; Hołówko W; Wronka KM; Grąt K; Lewandowski Z; Kosińska I; Krasnodębski M; Wasilewicz M; Gałęcka M; Szachta P; Zborowska H; Patkowski W; Krawczyk M
    Transpl Infect Dis; 2015 Apr; 17(2):174-84. PubMed ID: 25728703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota in cirrhotic liver transplant candidates.
    Grąt M; Hołówko W; Gałecka M; Grąt K; Szachtaz P; Lewandowsk Z; Kosińska I; Schmidts M; Olejnik-Schmidt A; Krawczyk M
    Hepatogastroenterology; 2014 Sep; 61(134):1661-7. PubMed ID: 25436359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in gut microbial function following liver transplant.
    Bajaj JS; Kakiyama G; Cox IJ; Nittono H; Takei H; White M; Fagan A; Gavis EA; Heuman DM; Gilles HC; Hylemon P; Taylor-Robinson SD; Legido-Quigley C; Kim M; Xu J; Williams R; Sikaroodi M; Pandak WM; Gillevet PM
    Liver Transpl; 2018 Jun; 24(6):752-761. PubMed ID: 29500907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis.
    Bajaj JS; Fagan A; Sikaroodi M; White MB; Sterling RK; Gilles H; Heuman D; Stravitz RT; Matherly SC; Siddiqui MS; Puri P; Sanyal AJ; Luketic V; John B; Fuchs M; Ahluwalia V; Gillevet PM
    Liver Transpl; 2017 Jul; 23(7):907-914. PubMed ID: 28240840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Inter-Laboratory Variability on Model of End-Stage Liver Disease (MELD) Score Calculation.
    Al-Saeedi M; Yassein T; Schultze D; Nickkholgh A; Bruns H; Zorn M; Hinz U; Ganten TM; Schemmer P
    Ann Transplant; 2016 Nov; 21():675-682. PubMed ID: 27799654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease.
    Dubinkina VB; Tyakht AV; Odintsova VY; Yarygin KS; Kovarsky BA; Pavlenko AV; Ischenko DS; Popenko AS; Alexeev DG; Taraskina AY; Nasyrova RF; Krupitsky EM; Shalikiani NV; Bakulin IG; Shcherbakov PL; Skorodumova LO; Larin AK; Kostryukova ES; Abdulkhakov RA; Abdulkhakov SR; Malanin SY; Ismagilova RK; Grigoryeva TV; Ilina EN; Govorun VM
    Microbiome; 2017 Oct; 5(1):141. PubMed ID: 29041989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Model for End-Stage Liver Disease score: an independent prognostic factor of mortality in injured cirrhotic patients.
    Inaba K; Barmparas G; Resnick S; Browder T; Chan LS; Lam L; Talving P; Demetriades D
    Arch Surg; 2011 Sep; 146(9):1074-8. PubMed ID: 21576598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis.
    Grąt M; Wronka KM; Krasnodębski M; Masior Ł; Lewandowski Z; Kosińska I; Grąt K; Stypułkowski J; Rejowski S; Wasilewicz M; Gałęcka M; Szachta P; Krawczyk M
    Transplant Proc; 2016 Jun; 48(5):1687-91. PubMed ID: 27496472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE
    J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum bilirubin in newborns affected by jaundice with gut microbiota dysbiosis.
    Zhou S; Wang Z; He F; Qiu H; Wang Y; Wang H; Zhou J; Zhou J; Cheng G; Zhou W; Xu R; Wang M
    J Nutr Biochem; 2019 Jan; 63():54-61. PubMed ID: 30342317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disorders of gut microflora in the pathogenesis of liver cirrhosis and complications of portal hypertension].
    Anikina EV; Kovtun AV; Iakovenko AV; Gioeva IZ; Iakovenko ÉP; Agafonova NA; Ivanov AN; Volosheĭnikova TV; Grigor'eva IuV
    Eksp Klin Gastroenterol; 2014; (12):20-3. PubMed ID: 26058107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis.
    Kaplan DE; Dai F; Skanderson M; Aytaman A; Baytarian M; D'Addeo K; Fox R; Hunt K; Knott A; Mehta R; Pedrosa M; Pocha C; Valderrama A; Taddei T;
    Dig Dis Sci; 2016 Nov; 61(11):3309-3320. PubMed ID: 27405990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
    Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The anaylsis of mortality rate according to CTP score and MELD score in patients with liver cirrhosis].
    Jeong EM; Hwang SG; Park HH; Park JH; Kim HT; Oh SW; Kho KH; Hong SP; Park PW; Rim GS; Kim SH
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):98-106. PubMed ID: 12824749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
    Londoño MC; Cárdenas A; Guevara M; Quintó L; de Las Heras D; Navasa M; Rimola A; Garcia-Valdecasas JC; Arroyo V; Ginès P
    Gut; 2007 Sep; 56(9):1283-90. PubMed ID: 17452425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease.
    Reddy KR; O'Leary JG; Kamath PS; Fallon MB; Biggins SW; Wong F; Patton HM; Garcia-Tsao G; Subramanian RM; Thacker LR; Bajaj JS;
    Liver Transpl; 2015 Jul; 21(7):881-8. PubMed ID: 25845966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score.
    Francoz C; Prié D; Abdelrazek W; Moreau R; Mandot A; Belghiti J; Valla D; Durand F
    Liver Transpl; 2010 Oct; 16(10):1169-77. PubMed ID: 20879015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary investigation of intestinal microflora in patients with hepatic cirrhosis].
    Wu X; Xu X; Lu Q; Dai YP; Wu ZM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):817-21. PubMed ID: 23206299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.